The landscape of metabolic brain alterations in Alzheimer’s disease is a dataset published in bioRxiv (Cold Spring Harbor Laboratory) (2021). On theSindex it has a DataRank of 0.508, placing it in the top 37.9% of the data-sharing corpus. It has been cited 8 times, with 6 citing works in its 1-hop citation network.
Ranks in the top 38% for downstream scientific impact
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.330
From this paper's citation signal
Citation Network Contribution
0.178
From 5 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 6 citers.
National Institutes of Health
Grant: 1RF1AG058942-01
Gut Liver Brain Biochemical Axis in Alzheimer's Disease
National Institutes of Health
Grant: 5U01AG061357-05
AMP-AD Brain Proteomic Network Enhancement, Validation, and Translation into CSF Biomarkers
National Institutes of Health
Grant: 1RF1AG059093-01
Metabolic Networks and Pathways Predictive of Sex Differences in AD Risk and Responsiveness to Treatment
National Institutes of Health
Grant: 7U01AG046152-05
Pathway discovery, validation and compound identification for Alzheimer's disease
National Institutes of Health
Grant: 3RF1AG051550-01S1
Metabolic Signatures Underlying Vascular Risk Factors for Alzheimer-type Dementias
National Institutes of Health
Grant: 1R01AG069901-01A1
TargetAD: A systems multi-omics approach to drug repositioning in Alzheimer's disease
National Institutes of Health
Grant: 5R01AG046171-03
Metabolic Networks and Pathways in Alzheimer's Disease
National Institutes of Health
Grant: 3U01AG061356-02S1
Multi-omic network-directed proteoform discovery, dissection and functional validation to prioritize novel AD therapeutic targets
National Institutes of Health
Grant: 5R01AG032990-02
Genome wide association study of gene expression levels in Alzheimer's disease
National Institutes of Health
Grant: 5U19AG063744-02
Alzheimer's Gut Microbiome Project
National Institutes of Health
Grant: 5R01AG017917-20
Epidemiologic Study of Neural Reserve and Neurobiology of Aging
National Institutes of Health
Grant: 3R01NS080820-02S1
Gene discovery in PSP by transcriptome, neuropathology and sequence analysis
National Institutes of Health
Grant: 3U01AG061359-05S1
Characterizing the AD Metabolome in Brain Tissue Samples of Individuals from Diverse Populations
National Institutes of Health
Grant: 1P30AG010161-01
SHORT-TERM STABILITY OF CLINICAL TESTS
National Institutes of Health
Grant: 2U01AG006786-04
ALZHEIMERS DISEASE PATIENT REGISTRY
National Institutes of Health
Grant: 5U01AG046139-10
A Systems Approach to Targeting Innate Immunity in AD
National Institutes of Health
Grant: 3P50AG016574-06S1
Mayo Alzheimers Disease Research Center
National Institutes of Health
Grant: 5R01AG018023-10
Plasma AB as a Surrogate Genetic Marker for LOAD
National Institutes of Health
Grant: 5P30AG072975-02
Rush Alzheimer's Disease Research Center
National Institutes of Health
Grant: 5R01AG015819-07
Risk Factors, Pathology, and Clinical Expressions of AD
Fields of Study
Keywords
Sustainable Development Goals